GALD.SW
GALD.SW
CH1335392721
GALDERMA GROUP N
Loading chart...

Company Profile

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.

Related stocks

SDZ.SW
SDZ.SW • Switzerland
SANDOZ GROUP N
69.72 CHF
36.35B USD 1Y +40.9%
HLN.L
HLN.L • United Kingdom
HALEON PLC ORD GBP0.01
349.2 GBp
40.64B USD 1Y +1%
MRK.DE
MRK.DE • Germany
MERCK KGAA I
137.85 EUR
67.16B USD 1Y +13%
SOBI.ST
SOBI.ST • Sweden
Swedish Orphan Biovitrum AB
428.4 SEK
14.92B USD 1Y +35.3%
IPN.PA
IPN.PA • France
IPSEN
142.7 EUR
13.18B USD 1Y +20.7%
600276.SS
600276.SS • China
JIANGSU HENGRUI PHARMACEUTICALS
46.85 CNY
46.53B USD 1Y -34.2%
KNSA
KNSA • United Kingdom
Kiniksa Pharmaceuticals Interna
79.78 USD
6.14B USD 1Y +105.6%
1276.HK
1276.HK • China
HENGRUI PHARMA
48 HKD
40.6B USD 1Y -45.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
32.9% p.a.
Max Drawdown (3Y)
-38.8%
Sharpe Ratio (3Y)
1.63
Beta Factor
-0.05
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 56.9 (Elevated multiple compression risk)
ende